HCAT healthcatalyst.com Long-Term Loans to Capital Ratio

Health Catalyst, Inc. (HCAT) is recognized as an authoritative expert in processing complex hospital data, enjoying the absolute trust of American medical professionals. The subscription-based business model minimizes macroeconomic impact, while the drive among clinics to reduce costs guarantees stable demand. The business is currently experiencing a period of rapid growth driven by the digitalization of networks, with the indicator standing at 1.64. The current stock quotes displayed on the GURU.Markets chart confirm this positive trend.
Metric breakdowns and analytics for Health Catalyst, Inc. (HCAT)

This indicator measures the degree of long-term financing dependence on equity, determining the balance sheet structure's resilience to cyclical changes in borrowing costs. Analyzing the long-term debt-to-equity ratio in the context of Health Catalyst (HCAT) deploying cloud AI platforms allows for an assessment of investment efficiency in subscription contract infrastructure, confirming the business's fundamental ability to scale its technology stack without critical debt load.